News & Analysis on Clinical Trial Services & Contract Research And Development
VGX and Dowpharma have signed an agreement to advance the development of a novel cancer compound currently in pre-clinical development that initial clinical studies will target individuals with Non-Hodgkin's Lymphoma.
Stem Cell Sciences have launched the first complete, defined medium that enables the large-scale, consistent production of mouse ES cells. The announcement closely follows the formation of an exclusive agreement completed last year between the two...
With a 30 per cent grip on the $100m (€84m) global customer relationship management (CRM) market from its dealings in the US, C3i is now taking on Europe - a market that holds similar potential to the US - and finding little competition in its path.
Datatrak's $18m (€15m) acquisition of ClickFind fulfills the company's strategy of offering the broadest multi-component eClinical capability in the clinical trials market.
Nucryst Pharmaceuticals has been granted a new patent that covers the company's proprietary nanocrystalline silver for use in the treatment of acne. This latest addition strengthens the company's patent portfolio, which now covers the top three...
Researchers in the US think they have identified a compound that interferes with the pathogenic effects of Huntington's disease that could lead to the development of a new treatment for the disease as well as making an impact on similar disorders such...
FEI and Sidec have entered into an agreement to commercialise a range of Protein Tomography solutions that could provide drug companies with services that could increase the chances of success in early stage drug development.